Development Status and Plans
Realizing ‘the new paradigm of treatment’
| Program | Symptom | Symptom | Partners | Discovery | PoC | Clinical Trials | Approval |
|---|---|---|---|---|---|---|---|
| DP-DTX-001 | Addiction |
AI based Alcohol & nicotine CBT |
CMC | ||||
| DP-DTX-002 | Hearing ability | Hearing Loss and Tinnitus |
CMC HALLYM University |
||||
| DP-DTx-003 | Mild cognitive impairment(MCI) | Cognitive Aging and Dementia |
CMC Ariacare |
||||
| DP-DTX-004 | ADHD | Electrostimulation and DTx for Pediatric ADHD Treatment |
CMC Ybrain NeuroSigma |
||||
| Program | Symptom | Symptom | Partners | Discovery | PoC | Clinical Trials | Approval |
|---|---|---|---|---|---|---|---|
| DP-DTX-005 | Dysphagia | DTx and electrical stimulation device for dysphagia management |
CMC Medical device company |
||||
| DP-DTX-006 | perinatal depression |
Software-based DTx for pregnant women |
CMC CHA Medical Center |
||||
| DP-CODIPAI | digital pathology |
AI-based digital pathology platform |
CMC Consortium MoH | ||||